We have observed
4 EP applications
René John Raggers
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after February 21, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
IMMUNOTHERAPY USING REDIRECTED ALLOGENEIC CELLS
MEDICAL DEVICES WITH COATINGS FOR ENHANCED ECHOGENICITY
MIRNAS INVOLVED IN THE BLOOD BRAIN BARRIER FUNCTION
An improved mutagenesis method using polyethylene glycol mediated introduction of mutagenic nucleobases into plant protoplasts